CLDX - Celldex Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue12,7436,7865,4803,586
Cost of Revenue96,171102,026100,171101,881
Gross Profit-83,428-95,240-94,691-98,295
Operating Expenses
Research Development----
Selling General and Administrative25,00332,37933,83720,622
Non Recurring----
Others----
Total Operating Expenses122,070135,402135,021123,516
Operating Income or Loss-109,327-128,616-129,541-119,930
Income from Continuing Operations
Total Other Income/Expenses Net-7,986862,3441,850
Earnings Before Interest and Taxes-109,327-128,616-129,541-119,930
Interest Expense----
Income Before Tax-117,313-128,530-127,197-118,080
Income Tax Expense-24,282---
Minority Interest----
Net Income From Continuing Ops-93,031-128,530-127,197-118,080
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-93,031-128,530-127,197-118,080
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-93,031-128,530-127,197-118,080